Results for: Quiz 1z0-076 - Oracle Database 19c: Data Guard Administration Marvelous Reliable Exam Sample 🔡 Download ▷ 1z0-076 ◁ for free by simply searching on “ www.pdfvce.com ” 😙1z0-076 Valid Test Tips

Record number of FDA drug approvals in 2018

January 9, 2019

…migraine (for a review see Holland & Goadsby. Neurotherapeutics 2018;15:304-312; free full text at www.ncbi.nlm.nih.gov/pmc/articles/PMC5935646/pdf/13311_2018_Article_617.pdf). Epidiolex (cannabidiol, Greenwich Research) was approved in June as an antiseizure add-on therapy for patients with Lennox-Gastaut syndrome and Dravet syndrome. The drug is a liquid solution taken twice-daily in combination with other antiseizure medications. Approval was b…

Rare cases of stroke reported with alemtuzumab

December 14, 2018

…erferon-gamma (Thomas et al. Neurol Neuroimmunol Neuroinflamm 2016;3:e228; free full text at www.ncbi.nlm.nih.gov/pmc/articles/pmid/27213173/). A cytokine storm was reported in the one patient who died of hemorrhagic stroke. Cytokine syndrome may manifest clinically as pyrexia, headache, malaise and urticarial rash, and may be associated with a transient worsening of neurological symptoms (Moreau et al. Brain 1996;119:225-237). The incidence of cy…

Improving QoL in patients with schizophrenia

December 5, 2018

…656; free full text at www.ncbi.nlm.nih.gov/pmc/articles/PMC6016599/pdf/ndt-14-1645.pdf). Patients were randomized to aripiprazole 400 mg once-monthly or paliperidone 100 mg once-monthly for one year; patients remained hospitalized until stable, then were followed as outpatients. QoL was evaluated with the World Health Organization (WHOQOL-BREF) scale, which assesses 26 items in four domains (physical and psychological health, social relationships…

Early diagnosis of MS – is it a myth?

November 28, 2018

…ars (Jacobs et al. Ann Neurol 1996;39:285-294). In the PRISMS trial of beta-IFN-1a, the mean age was 34.9 years with a mean disease duration of 5.3 years (PRISMS Study Group. Lancet 1998;352:1498-1504). In more contemporary studies, the average age at entry was generally older, with an older age at diagnosis. In the OPERA studies, the average age was 37.2 years with a mean time from diagnosis of 3.9 years (Hauser et al. N Engl J Med 2017;376:221-2…

Effect of MS treatment on cognitive dysfunction

November 15, 2018

…lay the onset of cognitive dysfunction. A majority of patients were relapse-free (80.6%) and had no six-month disability progression (94.1%) during the two-year observation period. DMF was also associated with beneficial effects on fatigue, depression and quality of life. The benefits of treatment on cognition may be due, in part, to effects on grey-matter pathology. A separate presentation at ECTRIMS compared the effect of DMF versus no treatment…